000 | 01999 a2200589 4500 | ||
---|---|---|---|
005 | 20250514181912.0 | ||
264 | 0 | _c20040430 | |
008 | 200404s 0 0 eng d | ||
022 | _a1087-2914 | ||
024 | 7 |
_a10.1089/108729104322740857 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aValer, Luisa | |
245 | 0 | 0 |
_aImpact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens. _h[electronic resource] |
260 |
_bAIDS patient care and STDs _cJan 2004 |
||
300 |
_a1-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aCarbamates |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Resistance, Viral |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFurans |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xblood |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLopinavir |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMutation _xdrug effects |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPyrimidinones _xtherapeutic use |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 |
_aRitonavir _xblood |
650 | 0 | 4 |
_aSalvage Therapy _xmethods |
650 | 0 | 4 |
_aSulfonamides _xblood |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aViral Load |
700 | 1 | _aGonzález de Requena, Daniel | |
700 | 1 | _ade Mendoza, Carmen | |
700 | 1 | _aMartin-Carbonero, Luz | |
700 | 1 | _aGonzález-Lahoz, Juan | |
700 | 1 | _aSoriano, Vincent | |
773 | 0 |
_tAIDS patient care and STDs _gvol. 18 _gno. 1 _gp. 1-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/108729104322740857 _zAvailable from publisher's website |
999 |
_c14726240 _d14726240 |